DDIT3 and breast cancer: Previous work from our lab showed that upregulation of DR5 at the mRNA level following ONC201 treatment in colorectal cells was blocked by knockdown of ISR mediators ATF4 and CHOP [11] and that ONC201 treatment activates an ISR in breast cancer cells [18].